Abstract:BackgroundHyperglycemia has been reported to be associated with the outcomes of patients in the intensive care unit (ICU). However, the relationship between hemoglobin A1c (HbA1c) and long-term or short-term mortality in the ICU is still unknown. This study used the Medical Information Mart for Intensive Care (MIMIC)-IV database to investigate the relationship between HbA1c and long-term or short-term mortality among ICU patients without a diabetes diagnosis.MethodsA total of 3,154 critically ill patients without a diabetes diagnosis who had HbA1c measurements were extracted and analyzed from the MIMIC-IV. The primary outcome was 1-year mortality, while the secondary outcomes were 30-day mortality and 90-day mortality after ICU discharge. HbA1c levels were classified into four levels according to three HbA1c values (5.0%, 5.7%, and 6.5%). The Cox regression model was used to investigate the relationship between the highest HbA1c measurement and mortality. Finally, this correlation was validated using the XGBoost machine learning model and Cox regression after propensity score matching (PSM).ResultsThe study eventually included 3,154 critically ill patients without diabetes who had HbA1c measurements in the database. HbA1c levels of below 5.0% or above 6.5% were significantly associated with 1-year mortality after adjusting for covariates in Cox regression (HR: 1.37; 95% CI: 1.02–1.84 or HR: 1.62; 95% CI: 1.20–2.18). In addition, HbA1c 6.5% was linked to 30-day mortality (HR: 1.81; 95% CI: 1.21–2.71) and 90-day mortality (HR: 1.62; 95% CI: 1.14–2.29). The restricted cubic spline demonstrated a U-shaped relationship between HbA1c levels and 1-year mortality. The AUCs of the training and testing datasets in the XGBoost model were 0.928 and 0.826, respectively, while the SHAP plot revealed that HbA1c was somewhat important for the 1-year mortality. Higher HbA1c levels in Cox regression were still significantly associated with 1-year mortality after PSM for other factors,ConclusionsThe 1-year mortality, 30-day mortality, and 90-day mortality rates for critically ill patients after discharge from ICU are significantly associated with HbA1c. HbA1c < 5.0% and ≥6.5% would increase 30-day, 90-day, and 1-year mortality, while levels between 5.0% and 6.5% of HbA1c did not significantly affect these outcomes.

The Complexity of Glucose Time Series is Associated with Short- and Long-Term Mortality in Critically Ill Adults: a Multi-Center, Prospective, Observational Study

Impact of the Complexity of Glucose Time Series on All-Cause Mortality in Patients with Type 2 Diabetes.

91-OR: Association Between Complexity of Glucose Time Series and All-Cause Mortality in Patients with Type 2 Diabetes Mellitus: A Prospective Cohort Study

Real-time Continuous Glucose Monitoring Versus Conventional Glucose Monitoring in Critically Ill Patients: a Systematic Review Study Protocol.

Decreasing Complexity of Glucose Time Series Derived from Continuous Glucose Monitoring is Correlated with Deteriorating Glucose Regulation

Threshold of hyperglycaemia associated with mortality in critically ill patients: a multicentre, prospective, observational study using continuous glucose monitoring

Accuracy of the intermittently scanned continuous glucose monitoring system in critically ill patients: a prospective, multicenter, observational study

Relationship between time-weighted average glucose and mortality in critically ill patients: a retrospective analysis of the MIMIC-IV database

The Impact of Diabetes on Mortality in Inpatients from Medical Department of A Chinese Tertiary Hospital

Between blood glucose and mortality in critically ill patients: Retrospective analysis of the MIMIC‐IV database

Decreased complexity of glucose time series index associated with adverse pregnancy outcomes in gestational diabetes mellitus

Subcutaneous Continuous Glucose Monitoring in Critically Ill Patients During Insulin Therapy: a Meta-Analysis.

Continuous Glucose Monitoring System Can Improve the Quality of Glucose Control and Glucose Variability Compared with Point-of-care Measurement in Critically Ill Patients

The Association of Mean Glucose Level and Glucose Variability with Intensive Care Unit Mortality in Patients with Severe Acute Pancreatitis

Impact of short-term glycemic variability on risk of all-cause mortality in type 2 diabetes patients with well-controlled glucose profile by continuous glucose monitoring: A prospective cohort study

1231-P: Decreased Complexity of Glucose Time Series Index Associated with Adverse Pregnancy Outcomes in Patients with Gestational Diabetes Mellitus—A Retrospective Cohort Study

Correlation between insulin-like growth factor and complexity of glucose time series index in patients with newly diagnosed acromegaly: a PILOT study

Correlation of Blood Glucose Variability with Severity and Short-Term Mortality in Critical Ill Patients

The Association Between Hemoglobin A1c and All-Cause Mortality in the ICU: A Cross-Section Study Based on MIMIC-IV 2.0.

Associations Between Complexity of Glucose Time Series and Cognitive Function in Adults with Type 2 Diabetes.

A Patient-Level Meta-Analysis of Intensive Glucose Control in Critically Ill Adults